PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer

PFDN2 promotes cell cycle progression via the hnRNPD-MYBL2 axis in gastric cancer

Gastric cancer (GC) is a major health burden worldwide, but our understanding of GC is limited, and the prognosis is poor. Novel therapeutic strategies and biomarkers are urgently needed to improve GC patient outcomes. Previously, we identified PFDN2 as a novel key gene in gastric cancer based on it...

Full description

Bibliographic Details
Main Authors: Qiuming He, Zheyu Ding, Tingna Chen, Haitao Wu, Jialing Song, Zhenxian Xiang, Chaogang Yang, Shuyi Wang, Bin Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Oncology
Subjects:
PFDN2
Cell Cycle
MYBL2
gastric cancer
HNRNPD
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1164070/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1164070/full

Similar Items